Lung cancer symposium nov 2020 | MedGenome

Lung cancer symposium nov 2020

MedGenome cordially invites you to a Virtual Symposium on

Lung cancer and Genetics

Date & Time:
7th November, 2020; 7pm IST

Lung cancer is the most common cancer diagnosed worldwide. It is also the foremost contributor to cancer-related mortality, resulting in 1.38 million cancer deaths per year worldwide. There is a significant burden of lung cancer in India as well.

The presence of genetic alterations in the cancer cells which drive the growth of the tumor (Driver Alterations) allows the selection of treatment regime for individual NSCLC patients.

Genetic testing identifies the presence of oncogenic drivers and hence helps indicate the apt targeted treatment regimen improving the probability of patient survival as well as the quality of life.

As a part of our endeavour to create awareness on the topic of lung cancer and the role of genetics, we bring together senior doctors and scientists from the field to speak with you and share experiences during this Lung Cancer Awareness Month.

This symposium will be an amalgamation of genetic diagnostics and clinical experience in cancer treatment. It will focus on genetic diagnostic approaches for lung cancer and how these have empowered doctors in clinical practice to make informed treatment decisions.

Speakers
Panelist
Dr. Boben Thomas

Consultant Medical & Pediatric Oncologist, Caritas Hospital Kottayam and GG Hospital, Trivandrum

Panelist
Dr. Tushar Patil

Consultant Medical Oncologist at Sahyadri Hospitals, Pune

Panelist
Dr. Mithun Shah

Senior Consultant Medical & Hemato Oncologist, Zydus Hospitals, Ahmedabad

Moderator
Dr. Arun Kumar

Scientific Affairs, Medgenome Labs

Agenda
7 p.m.Welcome and acknowledge the speakers and attendeesGanesh Mahajan, Marketing Manager, MedGenome Labs
7:05 p.m.Speaker IntroductionDr. Arun Kumar, Scientific Affairs, Medgenome Labs
7.10-7.30 p.m.Somatic EGFR Mutations in NSCLC and their Therapeutic ImplicationsDr. Boben Thomas, Consultant Medical & Pediatric Oncologist, Caritas Hospital Kottayam and GG Hospital, Trivandrum.
7:30-7.50 p.m.Molecular and Genetic Aspects of Lung Cancer
Dr. Tushar Patil, Consultant Medical Oncologist at Sahyadri Hospitals, Pune
7.50 – 8:10 p.m.PD L1 testing and its significance in Lung CancerDr. Mithun Shah, Senior Consultant Medical & Hemato Oncologist, Zydus Hospitals, Ahmedabad
8.10 – 8:30 p.m.Genomic technologies in NSCLC testing and interpreting Next Generation Sequencing ReportsDr. Arun Kumar, Scientific Affairs, Medgenome Labs
8.30- 8:40 p.m.Open the floor for Q+A OR The anchor to read out the questions to be addressed.Ganesh Mahajan, Marketing Manager, MedGenome Labs

Can't attend live? You can still REGISTER! We will share the recording of the webinar with all registrants.

Future Medicine

Test Menu

Genetic Counselling

Microsites

Collaterals

Contact Us